S-ICDs : advantages and opportunities for improvement

Article Article scientifique Revue de la littérature S-ICDs : advantages and opportunities for improvement eng 2022-03-17 2022-03-17 author Friedli Axel Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland 699363 author Burri Haran Kumar 0000-0002-4393-5338 Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland 29514 Département de médecine (DEMED) 237-245 10.1080/17434440.2022.2054335 35289702 1743-4440 https://www.tandfonline.com/doi/full/10.1080/17434440.2022.2054335 Introduction: The subcutaneous implantable cardioverter defibrillator (S-ICD) is currently in its third generation and has been adopted in guidelines and in mainstream clinical practice. Considerable improvements have been made since the introduction of this device over a decade ago. Areas covered: A literature search was undertaken in Pubmed on articles relating to the S-ICD. Expert opinion: The therapy has been proven to be safe and effective and is a valuable option in selected patients. Nevertheless, there remain many shortcomings of the S-ICD which are discussed in this review, and which hopefully will be addressed by future generations of the device. CIED S-ICD Subcutaneous implantable cardioverter defibrillator Cardiac implantable electronic device Implantable cardioverter defibrillator Dewey 616 56 Département de médecine 221 false Expert review of medical devices 19 3 6563ac46-ca59-4626-8cdf-dd7ecc83902c Article (Published version) Restricted S-ICDs advantages and opportunitie.pdf 4494551 application/pdf d3491cc3ff208cecb4f3e4a115f941c856e5f96ee07c9de501eef3d448bee9ea restrictedAccess Faculté de médecine / Section de médecine clinique / Département de médecine

Title	Published in	Access level	OA Policy	Year	Views	Downloads

S-ICDs : advantages and opportunities for improvement	Expert review of medical devices			2022	70	0

Archive ouverte UNIGE

Friedli, Axel